A point mutation in CD28 distinguishes proliferative signals from survival signals.
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Upon interaction with its ligand, B7, CD28 becomes phosphorylated on tyrosines. One tyrosine in particular (Y170 in mouse CD28, Y173 in human CD28) has received much attention. This is because it permits CD28 to recruit SH2-containing signaling molecules, including phosphoinositide 3 kinase, Grb2 and Gads. Using mice we employed a transgenic approach to express a tyrosine-->phenylalanine mutant form of CD28 that uncouples these SH2-mediated interactions from CD28. The CD28 mutant is unable to up-regulate expression of the prosurvival protein Bcl-xL, rendering the T cells more susceptible to radiation-induced death. Nonetheless, this mutated form of CD28 still prevents the induction of anergy and promotes T cell proliferation, interleukin 2 secretion and B cell help. Thus, we describe a single point mutation within the CD28 cytoplasmic domain that uncouples signals required for proliferation and survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This suggests that PI3K or its downstream effector AKT [34], [35] is mandatory (although not sufficient) for CD28SA-mediated IFN-γ production.”
From Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies (2008) · cites this paper as [35]
Citations
Cites
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · cited 1×
“gif" NDATA ITEM> ]> CD28 provides costimulatory signals to T cells that prevent the induction of anergy and cell death and promote interleukin 2 (IL-2) production and clonal expansio”
BackgroundSH2 domains recognize specific phosphopeptide sequences
Zhou, S. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,631 · cited 1×
“Class I A PI3Ks assemble into larger protein complexes via interaction of the p85 SH2 domains with tyrosine-phosphorylated YxxM motifs that are present on a number of cell-surface receptors and cytosolic protein”
The PI3K‒PDK1 connection: more than just a road to PKB
Vanhaesebroeck, B., & Alessi, D. R. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460561 · Cited by 1,644 · cited 1×
“To determine whether CD28-dependent activation of the PI3K pathway was abrogated in Y170F Tg mice, we assessed the phorphorylation state of PKB after CD28 stimulation as a surrogate indicator of phosphatidyl inositol-3-phosphate lipid productio”
MethodDifferential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257 · cited 1×
“Because CD28 is required for a secondary humoral respons”
BackgroundSelf-citationCD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210 · cited 1×
“CD28-mediated up-regulation of Bcl-x L expression CD28 promotes T cell survival and may do so by increasing the expression of Bcl-x L”
BackgroundFunction of PI3Kγ in Thymocyte Development, T Cell Activation, and Neutrophil Migration
Sasaki, T., Irie-Sasaki, J., Jones, R. G., Oliveira-dos-Santos, A. J., Stanford, W. L., Bolon, B., Wakeham, A., Itie, A., Bouchard, D., Kozieradzki, I., et al. (2000) · Science · doi:10.1126/science.287.5455.1040 · Cited by 1,031 · cited 1×
“Mice that are deficient in p110γ, a PI3K family member which does not require p85 for its recruitment to receptors, produce reduced amounts of interferon γ and IL-2 in response to CD3 and CD28 stimulatio”
BackgroundSelf-citationPhosphoinositide 3-kinases: A conserved family of signal transducers
Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., & Waterfield, M. D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01061-x · Cited by 954 · cited 1×
“Class 1 A PI3Ks are heterodimeric proteins that consist of a p110α, β or δ catalytic subunit and a p85 α, β or p55γ regulatory subuni”
BackgroundSignaling by Distinct Classes of Phosphoinositide 3-Kinases
Vanhaesebroeck, B., & Waterfield, M. D. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4701 · Cited by 853 · cited 1×
“Protein kinase B (or PKB, also known as Akt), Vav and Itk are examples of signaling proteins that require PI3K for their activatio”
BackgroundImpaired B Cell Development and Proliferation in Absence of Phosphoinositide 3-Kinase p85α
Fruman, D. A., Snapper, S. B., Yballe, C. M., Davidson, L., Yu, J. Y., Alt, F. W., & Cantley, L. C. (1999) · Science · doi:10.1126/science.283.5400.393 · Cited by 516 · cited 1×
“In contrast, T cells from mice that lack expression of the p85 subunit of PI3K respond normally to CD3 and CD28 stimulatio”
BackgroundBinding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling
Pagès, F., Ragueneau, M., Rottapel, R., Truneh, A., Nunes, J., Imbert, J., & Olive, D. (1994) · Nature · doi:10.1038/369327a0 · Cited by 398
Self-citation
Cited by
Items 101–200 of 212
Inducible T‐cell co‐stimulator: Signaling mechanisms in T follicular helper cells and beyond
Panneton, V., Chang, J., Witalis, M., Li, J., & Suh, W. (2019) · Immunological Reviews · doi:10.1111/imr.12771 · Cited by 59
Saibil, S. D., Jones, R. G., Deenick, E. K., Liadis, N., Elford, A. R., Vainberg, M. G., Baerg, H., Woodgett, J. R., Gerondakis, S., & Ohashi, P. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2932 · Cited by 50
Self-citationThe Role of B7 Family Molecules in Maternal–Fetal Immunity
Zhao, Y., Zheng, Q., & Jin, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00458 · Cited by 49
“Further studies using transgenic mice have highlighted the prominent function of CD28-induced PI3K pathways in regulating T-cell trafficking (10).”
BackgroundIndependent CD28 signaling via VAV and SLP‐76: a model for in trans costimulation
Rudd, C. E., & Raab, M. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00005.x · Cited by 46
Sanchez-Lockhart, M., Graf, B., & Miller, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7639 · Cited by 46
Dennehy, K. M., Elias, F., Na, S.-Y., Fischer, K.-D., Hünig, T., & Lühder, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1363 · Cited by 45
Hinterberger, M., Wirnsberger, G., & Klein, L. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00030 · Cited by 39
“However, given the evidence that the PI3-kinase pathway is important for induction of Bcl-xL by CD28 (Burr et al., 2001; Okkenhaug et al., 2001), yet that the PI3K interacting motif in CD28 is dispensable for efficient Treg induction (Tai et al.”
BackgroundA Transendocytosis Perspective on the CD28/CTLA-4 Pathway
Soskic, B., Qureshi, O. S., Hou, T., & Sansom, D. M. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800147-9.00004-2 · Cited by 45
Wood, J. E., Schneider, H., & Rudd, C. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604878200 · Cited by 42
A two-signal model for T cell trafficking
Marelli‐Berg, F. M., Okkenhaug, K., & Mirenda, V. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.04.008 · Cited by 41
Self-citationSyk mediates BCR- and CD40-signaling integration during B cell activation
Ying, H., Li, Z., Yang, L., & Zhang, J. (2011) · Immunobiology · doi:10.1016/j.imbio.2010.09.016 · Cited by 40
“Akt is a major target of PI3-K, and the phosphorylation state of Akt has been used as a surrogate indicator of PI3-K activation (Kane et al., 2001;Okkenhaug et al., 2001;Hirsch et al., 2000).”
MethodCD28 and ITK signals regulate autoreactive T cell trafficking
Jain, N., Miu, B., Jiang, J., McKinstry, K. K., Prince, A., Swain, S. L., Greiner, D. L., Thomas, C. J., Sanderson, M. J., Berg, L. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3393 · Cited by 44
Phosphatidylinositol 3-Kinase p85 Adaptor Function in T-cells
Kang, H. K., Schneider, H., & Rudd, C. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107648200 · Cited by 44
Pagán, A. J., Pepper, M., Chu, H., Green, J. M., & Jenkins, M. K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103231 · Cited by 39
The signaling tool box for tyrosine-based costimulation of lymphocytes
Engels, N., & Wienands, J. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.01.005 · Cited by 44
Effect of rapamycin on the cyclosporin A–resistant CD28-mediated costimulatory pathway
Ghosh, P., Buchholz, M. A., Yano, S., Taub, D. D., & Longo, D. L. (2002) · Blood · doi:10.1182/blood-2001-11-0062 · Cited by 41
Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activation
Parry, R. V., Riley, J. L., & Ward, S. G. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.02.004 · Cited by 43
p85β phosphoinositide 3-kinase regulates CD28 coreceptor function
Alcázar, I., Cortés, I., Zaballos, Á., Hernandez, C., Fruman, D. A., Barber, D. F., & Carrera, A. C. (2009) · Blood · doi:10.1182/blood-2008-04-152942 · Cited by 38
Garapati, P. V., & Lefranc, M. (2007) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2007.01.008 · Cited by 37
“Mutations of the LDN residues of the (109)MYPPPYLDN(117) motif of CD28 reduced both B7-1 and B7-2 binding, whereas mutations of Y(110) and Y(114) selectively reduced B7-2 binding without impacting upon B7-1 binding [53].”
BackgroundSanchez-Lockhart, M., & Miller, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4778 · Cited by 35
Activation and inhibition of lymphocytes by costimulation
Frauwirth, K. A., & Thompson, C. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214941 · Cited by 58
B7-2 (CD86) Controls the Priming of Autoreactive CD4 T Cell Response against Pancreatic Islets
Yadav, D., Judkowski, V. A., Flodström‐Tullberg, M., Sterling, L., Redmond, W. L., Sherman, L. A., & Sarvetnick, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3631 · Cited by 34
Two pathways of costimulation through CD28
Miller, J., Baker, C. M., Cook, K. D., Graf, B. A., Sánchez-Lockhart, M., Sharp, K., Wang, X., Yang, B. C., & Yoshida, T. (2009) · Immunologic Research · doi:10.1007/s12026-009-8097-6 · Cited by 40
“A defect in Bcl-XL induction and T cell homing was noted [52, 54, 57] , but there was little overall impact on the immune response and T cell activation resulted in normal levels of IL-2 secretion.”
BackgroundInfluentialTooley, K., Jerby‐Arnon, L., Escobar, G., Krovi, S. H., Mangani, D., Dandekar, G., Cheng, H., Madi, A., Goldschmidt, E., Lambden, C., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101640 · Cited by 35
Evidence Implicating the Ras Pathway in Multiple CD28 Costimulatory Functions in CD4+ T Cells
Janardhan, S. V., Praveen, K., Marks, R., & Gajewski, T. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024931 · Cited by 32
Memory T‐cell trafficking: new directions for busy commuters
Marelli‐Berg, F. M., Fu, H., Vianello, F., Tokoyoda, K., & Hamann, A. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03278.x · Cited by 35
Co-stimulate or Co-inhibit Regulatory T Cells, Which Side to Go?
Liu, W., Almo, S. C., & Zang, X. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1186690 · Cited by 34
“CD28 activation also renders T cells more resistant to apoptosis by upregulation of the prosurvival protein Bcl-xL (Okkenhaug et al., 2001; Wu et al., 2005).”
BackgroundT lymphocyte trafficking: molecules and mechanisms
Marelli‐Berg, F. M. (2012) · Frontiers in bioscience · doi:10.2741/4111 · Cited by 32
Boomer, J. S., Deppong, C. M., Shah, D. D., Bricker, T. L., & Green, J. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301240 · Cited by 29
CD28 Costimulation: A Source of Vav-1 for TCR Signaling with the Help of SLP-76?
Michel, F., & Acuto, O. (2002) · Science Signaling · doi:10.1126/stke.2002.144.pe35 · Cited by 38
CD28-dependent HIV-1 Transcription Is Associated with Vav, Rac, and NF-κB Activation
Cook, J. A., Albacker, L. A., August, A., & Henderson, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302878200 · Cited by 31
Muscolini, M., Camperio, C., Capuano, C., Caristi, S., Piccolella, E., Galandrini, R., & Tuosto, L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203157 · Cited by 31
Singh, N., Yamamoto, M., Takami, M., Seki, Y., Takezaki, M., Mellor, A. L., & Iwashima, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900753 · Cited by 26
Muscolini, M., Sajeva, A., Caristi, S., & Tuosto, L. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.01.011 · Cited by 27
ICOS ligand expression is essential for allergic airway hyperresponsiveness
Kadkhoda, K., Wang, S., Fan, Y., Qiu, H., Basu, S., Halayko, A. J., & Yang, X. (2011) · International Immunology · doi:10.1093/intimm/dxq476 · Cited by 25
Huang, S., Tsai, H.-F., Tzeng, H.-T., Liao, H., & Hsu, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001092 · Cited by 25
4-1BBL costimulation retrieves CD28 expression in activated T cells
Habibagahi, M., Jaberipour, M., & Searle, P. F. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.01.003 · Cited by 24
TGF-β Converts Apoptotic Stimuli into the Signal for Th9 Differentiation
Takami, M., Love, R. B., & Iwashima, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102698 · Cited by 24
“Therefore, it is possible that differential signaling is provided to the PI3K/Akt signaling pathway from CD28 when stimulation is provided by plate-bound or by soluble anti-CD28 Ab.”
BackgroundMethodInfluentialTyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo
Yi, L. A. (2004) · International Immunology · doi:10.1093/intimm/dxh055 · Cited by 24
Parry, R. V., Whittaker, G. C., Sims, M., Edmead, C. E., Welham, M. J., & Ward, S. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.594 · Cited by 23
Signal Transduction Via Co-stimulatory and Co-inhibitory Receptors
Ogawa, S., & Abe, R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_4 · Cited by 23
Vatzia, E., Pierron, A., Saalmüller, A., Mayer, E., & Gerner, W. (2019) · Toxins · doi:10.3390/toxins11110644 · Cited by 22
“Upon CD28 stimulation, high levels of IL-2 are produced, which enhance the viability and proliferation of T cells [22,24].”
BackgroundMolecular Architecture of Signal Complexes Regulating Immune Cell Function
Torgersen, K. M., Aandahl, E. M., & Taskén, K. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72843-6_14 · Cited by 20
Tolerance induction in memory CD4 T cells requires two rounds of antigen-specific activation
David, A. P., Crawford, F., Garside, P., Kappler, J. W., Marrack, P., & MacLeod, M. K. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406218111 · Cited by 19
“Whereas costimulatory signals that promote T-cell activation and cell survival are closely linked (29), the intracellular molecules that transmit these signals can be distinct (30, 31).”
BackgroundLuff, D. H., Wojdyła, K., Oxley, D., Chessa, T. A. M., Hudson, K., Hawkins, P. T., Stephens, L., Barry, S. T., & Okkenhaug, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631271 · Cited by 19
“However, subsequent studies have shown that the CD28-p85 interaction is not required for PI3K activation at the immune synapse in naïve or previously-activated T cells (9, 43), and that ICOS ligation induces higher PI3K activity than CD28 ligation (38, 44, 45), which may underpin the dominant role for ICOS in PI3K sig…”
BackgroundSelf-citationLi, G., Wu, X., Zhang, F., Li, X., Sun, B., Yu, Y., Yin, A., Deng, L., Yin, J., & Wang, X. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0905-9 · Cited by 18
“Okkenhaug et al. employed a transgenic approach to induce Y170F mutation in CD28, which prevented the induction of anergy and promoted T-cell proliferation, interleukin 2 secretion and B cell help (Okkenhaug et al. 2001).”
BackgroundOgawa, S., Watanabe, M., Sakurai, Y., Inutake, Y., Watanabe, S., Tai, X., & Abe, R. (2013) · International Immunology · doi:10.1093/intimm/dxt028 · Cited by 18
Locke, F. L., Zha, Y., Zheng, Y., Driessens, G., & Gajewski, T. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202018 · Cited by 16
DeBerg, H. A., Konecny, A., Shows, D. M., & Lord, J. D. (2022) · ImmunoHorizons · doi:10.4049/immunohorizons.2200009 · Cited by 16
ICOS Contributes to T Cell Expansion in CTLA-4 Deficient Mice
van Berkel, M. E. A. T., Schrijver, E. H. R., Hofhuis, F. M., Sharpe, A. H., Coyle, A. J., Broeren, C. P. M., Tesselaar, K., & Oosterwegel, M. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.182 · Cited by 15
“Whether ICOS induces an intrinsic cell survival mechanism independent from proliferation like CD28 does by up-regulation of Bcl-xL (39, 40) is currently under investigation.”
BackgroundThe regulatory subunit of PDE6 interacts with PACSIN in photoreceptors.
Houdart, F., Girard-Naud, N., Morin, F., Voisin, P., & Vannier, B. (2005) · PubMed · Cited by 15
Fowler, D. H., Bishop, M. R., & Gress, R. E. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.11.003 · Cited by 15
T Cell Costimulation through CD28 Depends on Induction of the Bcl-xγ Isoform
Ye, Q., Press, B., Kissler, S., Yang, X., Lu, L., Bassing, C. H., Sleckman, B. P., Jansson, M., Panoutsakopoulou, V., Trimble, L. A., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012084 · Cited by 15
Gogishvili, T., Elias, F., Emery, J. L., McPherson, K., Okkenhaug, K., Hünig, T., & Dennehy, K. M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838223 · Cited by 15
Self-citationAnnibaldi, A., Sajeva, A., Muscolini, M., Ciccosanti, F., Corazzari, M., Piacentini, M., & Tuosto, L. (2008) · European Journal of Immunology · doi:10.1002/eji.200737854 · Cited by 14
Graham, D. B., Bell, M. P., Huntoon, C. J., Griffin, M. D., Tai, X., Singer, A., & McKEAN, D. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6098 · Cited by 14
Li, Y., Schneider, H., & Rudd, C. E. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0702365 · Cited by 13
Lai, P., Weng, J., Lu, Z., Guo, R., Luo, C., Wu, S., Ling, W., Geng, S., & Du, X. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1284 · Cited by 12
“CD28 can directly bind to PI3K by a well-characterized YMNM binding motif in its cytoplasmic domain (Cai et al., 1995; Okkenhaug et al., 2001), and PI3K signaling pathway is considered to be important for CD28-mediated costimulation (Pages et al., 1994).”
BackgroundT cell trafficking and metabolism: novel mechanisms and targets for immunomodulation
Mauro, C., Fu, H., & Marelli‐Berg, F. M. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.02.018 · Cited by 13
Keller, A. M., & Borst, J. G. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.03.013 · Cited by 11
Lumsden, J. M., Prasad, S. J., Peach, R., & Ronchese, F. (2003) · European Journal of Immunology · doi:10.1002/eji.200323929 · Cited by 11
Chu, Y.-P., Taylor, D. K., Yan, H.-G., Diamond, B., & Spatz, L. A. (2002) · International Immunology · doi:10.1093/intimm/14.1.45 · Cited by 11
Charles, J., Vrionis, A., Mansur, A., Mathias, T. J., Shaikh, J., Ciner, A., Jiang, Y., & Nezami, N. (2023) · Cancers · doi:10.3390/cancers15092624 · Cited by 8
“mutation on CD28 converted T-cells from a survival state into a proliferative state [173].”
BackgroundChang, C., Wu, C., Chen, I., Hsu, K., Ho, H., Chuang, I.-P., & Lu, Y. (2012) · International journal of gerontology · doi:10.1016/j.ijge.2012.11.014 · Cited by 7
Nishikawa, T., Takeuchi, A., Machiyama, H., Wakamatsu, E., Nishijima, H., Furuhata, M., Toyota, H., Nishi, W., Matsushima, R., Yoshida, Y., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08906-y · Cited by 6
“This heterodimeric lipid kinase contributes to the production of phosphatidylinositol 3,4,5-triphosphate (PIP3), which induces activation of the Akt/mTOR pathway, promoting cell proliferation and survival 36,37 .”
Regulation of T-cell migration by co-stimulatory molecules
David, R., & Marelli‐Berg, F. M. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351114 · Cited by 6
Doepfner, K. T., Boller, D., Laurentiis, A. D., Guerreiro, A., Marinov, M., & Arcaro, A. (2007) · Recent Patents on DNA & Gene Sequences · doi:10.2174/187221507779814461 · Cited by 7
Genetic Analysis of CD28 Signaling
Greene, T. A., & Shapiro, V. S. (2003) · Immunologic Research · doi:10.1385/ir:27:2-3:513 · Cited by 6
Dynamic Motile T Cells Highly Respond to the T Cell Stimulation via PI3K-Akt and NF-κB Pathways
Kim, H., Na, B.-R., Kwon, M., Ko, Y., Han, W., & Jun, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059793 · Cited by 5
Exploring the controversial role of PI3K signalling in CD4+ regulatory T (T-Reg) cells
Poli, A., Fiume, R., Mongiorgi, S., Zaurito, A. E., Sheth, B., Vidalle, M. C., Abdul-Hamid, S., Kimber, S. T., Campagnoli, F., Ratti, S., et al. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100722 · Cited by 5
Cancer-Associated Immune Deficiency: A Form of Accelerated Immunosenescence?
Chang, C., Wu, C., & Lu, Y. (2012) · InTech eBooks · doi:10.5772/24367 · Cited by 7
“CD28 provides a co-stimulatory signal to interact with B7 molecules expressed on APCs and amplifies the signals delivered via the TCR, including increased cytokine expression, promotion of T-cell proliferation, and survival (Okkenhaug et al., 2001; Viola et al., 1999).”
BackgroundRuminski, K., Celis‐Gutierrez, J., Jarmuzynski, N., Maturin, E., Audebert, S., Malissen, M., Camoin, L., Voisinne, G., MALISSEN, B., & Roncagalli, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139123 · Cited by 4
“interaction with CD28 was important for IL-2 secretion (32, 33).”
BackgroundLee, H., & Kwon, B. S. (2007) · Springer eBooks · doi:10.1007/0-387-32829-7_2 · Cited by 3
“CD28/CTLA-4 –CD80 (B7-1)/CD86 (B7-2) is the best-studied co-stimulatory pathway (June et al., 1990; Lenschow et al., 1996; Mueller, 2000; Okkenhaung et al., 2001; Watts and DeBenedette, 1999).”
Graft-vs.-Host Disease as a Th1-Type Process: Regulation by Th2-Type Cells
Fowler, D. H., & Gress, R. E. (2004) · CRC Press eBooks · doi:10.1201/b14165-4 · Cited by 5
CD4/CD8–p56lck Induced T-Cell Receptor Signaling and Its Implications for Immunotherapy
Oroya, A., & Rudd, C. E. (2025) · Biomolecules · doi:10.3390/biom15081096 · Cited by 2
“In the case of CD28, we and others have defined key domains that promote CAR T-cell survival [9,11,86,87].”
Shukshin, A. A., Rubinstein, A. A., Golovkin, A. S., Moiseeva, O. M., & Kudriavtsev, I. V. (2025) · Medical academic journal · doi:10.17816/maj641689 · Cited by 1
Co-Receptors in the Positive and Negative Regulation of T-Cell Immunity
Schneider, H., & Rudd, C. E. (2008) · Springer eBooks · doi:10.1007/978-4-431-73884-8_8 · Cited by 1
Role of the redox responsive transcription factor, NRF2 in immune cell function
Hamdam, J. M. (2014) · University of Liverpool · doi:10.17638/00014133 · Cited by 3
Semple, K. M. (2011) · Digital Commons - University of South Florida (University of South Florida)
Brown, D. S. (2005) · eScholarship@UMassChan · doi:10.13028/eqwy-6j58
li, Y. (2010) · Digital Commons-TMC (Texas Medical Center) · Cited by 1
Ward, S. G. (2010) · Translational research in biomedicine · doi:10.1159/000274476
Castillo-Méndez, S. I. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2011.tde-26102011-170611
Development and use of a mouse model to investigate β-lactam hypersensitivity reactions
Nattrass, R. G. (2015) · University of Liverpool · doi:10.17638/00019433
Proliferation or survival: T-cell careers dissected at a molecular level
Michie, C. A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02066-4
Pagán, A. J. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Furlong, S. J. (2012) · Library and Archives Canada (Government of Canada)
Karlsson, E. A. (2010) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/z7a5-ph53
Abraham, R. T., Tuosto, L., Costanzo, A., Levrero, M., Spadaro, F., & Ramoni, C. (2017)
Late Antigen Regulates the Differentiation of Cytotoxic CD4 T Cells in Influenza Infection
Vong, A. M. (2017) · eScholarship@UMassChan · doi:10.13028/m2nt1p
“As CD28 also promotes survival and proliferation of cells (196) the lack of a requirement for late CD80/CD86 may suggest a regulatory role where increased proliferation and survival is not turned on to prevent overt expansion of cytotoxic ThCTL beyond the effector response.”
BackgroundFruman, D. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.739700984.793585934
Faculty Opinions recommendation of CD28 costimulation: from mechanism to therapy.
Tuosto, L. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726363559.793546230
Okkenhaug, K. (2005) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a000548.01
Self-citationPark, S. Y., Jang, W. Y., Jun, D. Y., & Kim, Y. H. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4534168
Santamaria, J. C. (2020) · theses.fr (ABES) · doi:10.70675/1acde594zefecz4343z8f7bzacfd6b21c6af
Park, S. Y., Kim, K. Y., Jang, W. Y., Bae, Y., Jun, D. Y., & Kim, Y. H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113998
Dérégulation de MYC dans les Leucémies Aiguës Lymphoblastiques T
Bonnet, M. (2011) · theses.fr (ABES) · doi:10.70675/155c08ffz3d83z4d03zb503z2fa5305b47d6
Metadata
- Authors
- Okkenhaug, K., Wu, L., Garza, K. M., La Rose, J., Khoo, W., Odermatt, B., Mak, T. W., Ohashi, P. S., & Rottapel, R.
- Affiliations
- University of Toronto (CA)
- Princess Margaret Cancer Centre (CA)
- Amgen (Canada) (CA)
- University of Zurich (CH)
- St. Michael's Hospital (CA)
- Corresponding author
- Rottapel, Robert
- Venue
- Nature Immunology
- Published
- 2001-04
- Volume
- 2
- Issue
- 4
- Pages
- 325-332
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W118130514
- Cited by
- 210
- References
- 49
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 5 · 2018: 2 · 2017: 5 · 2016: 5 · 2015: 2 · 2014: 8 · 2013: 7 · 2012: 10
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- CD28, B7, tyrosine phosphorylation, phosphatidylinositol 3-kinase, Grb2, GAD, T cell proliferation, T cell survival, Bcl-xL, radiation-induced apoptosis, T cell anergy, interleukin-2, B cell help, transgenic mice
- MeSH terms
- Animals, B-Lymphocytes, Cell Division, Cell Survival, Humans, Immunoglobulins, Interleukin-2, Lymphocyte Cooperation, Lymphocyte Activation, Mice, Inbred C57BL, Mice, Transgenic, Phosphorylation, T-Lymphocytes, Tyrosine, Signal Transduction, Gene Expression, Point Mutation, Clonal Anergy, CD28 Antigens, Mice, Knockout, src Homology Domains, Proto-Oncogene Proteins c-bcl-2, Phosphatidylinositol 3-Kinases, bcl-X Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.